Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,561,332 shares of IPA stock, worth $530,852. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,561,332
Previous 1,558,892
0.16%
Holding current value
$530,852
Previous $996,000
35.44%
% of portfolio
0.03%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$26,5880.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$14,0080.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$13,9760.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$12,0040.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$9,1140.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $8.44M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...